SEC Form 4 · accession 0001209191-18-006465
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Cole
Officer — Chief Legal Officer
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2018 | M | 25,000 | $22.53 | A | 44,798 | D | |
| Common StockF2 | Jan 30, 2018 | S | 1,160 | $192.4915 | D | 43,638 | D | |
| Common StockF3 | Jan 30, 2018 | S | 5,359 | $193.7441 | D | 38,279 | D | |
| Common StockF4 | Jan 30, 2018 | S | 6,743 | $194.6527 | D | 31,536 | D | |
| Common StockF5 | Jan 30, 2018 | S | 2,951 | $195.5664 | D | 28,585 | D | |
| Common StockF6 | Jan 30, 2018 | S | 2,458 | $196.6336 | D | 26,127 | D | |
| Common StockF7 | Jan 30, 2018 | S | 2,027 | $197.6062 | D | 24,100 | D | |
| Common StockF8 | Jan 30, 2018 | S | 710 | $198.462 | D | 23,390 | D | |
| Common StockF9 | Jan 30, 2018 | S | 1,003 | $199.4324 | D | 22,387 | D | |
| Common StockF10 | Jan 30, 2018 | S | 1,062 | $200.8818 | D | 21,325 | D | |
| Common StockF11 | Jan 30, 2018 | S | 1,113 | $201.574 | D | 20,212 | D | |
| Common StockF12 | Jan 30, 2018 | S | 296 | $202.6799 | D | 19,916 | D | |
| Common StockF13 | Jan 30, 2018 | S | 118 | $203.60 | D | 19,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F14 | $22.53 | Jan 30, 2018 | M | 25,000 | D | — | Feb 10, 2024 | Common Stock | 25,000 | 6,686 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017
- F10The range in prices for the transaction reported on this line was $200.20 to $201.10 The average weighted price was $200.8818. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F11The range in prices for the transaction reported on this line was $201.30 to $202.05. The average weighted price was $201.5740. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F12The range in prices for the transaction reported on this line was $202.40 to $203.00. The average weighted price was $202.6799. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F13The range in prices for the transaction reported on this line was $203.50 to $203.70. The average weighted price was $203.60. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F14This option vests over a four-year period, at a rate of twenty-five percent (25%) on March 6, 2015 and in 36 equal monthly installments thereafter.
- F2The range in prices for the transaction reported on this line was $192.00 to $192.95. The average weighted price was $192.4915. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $193.10 to $194.05. The average weighted price was $193.7441. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $194.10 to $195.05. The average weighted price was $194.6527. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $195.10 to $196.05. The average weighted price was $195.5664. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range in prices for the transaction reported on this line was $196.10 to $197.05. The average weighted price was $196.6336. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range in prices for the transaction reported on this line was $197.10 to $198.00. The average weighted price was $197.6062. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range in prices for the transaction reported on this line was $198.10 to $199.00. The average weighted price was $198.4620. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9The range in prices for the transaction reported on this line was $199.10 to $200.05. The average weighted price was $199.4324. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.